Pharmacological therapy of surgical disease often involves manipulatin
g the physiologic balance between pro; and anti-inflammatory responses
. Many agents target only one aspect of the inflammatory cascade. Orig
inally identified as a protein elaborated by T-lymphocytes, IL-IO appe
ars to globally inhibit cytokine production. the purpose of this manus
cript is to examine the immunomodulatory and anti-inflammatory effects
of interleukin-10 (IL-10) in an attempt to define the clinical utilit
y of IL-10, both as a marker of and as a therapeutic strategy for inte
rvention in inflammatory and immune-mediated diseases. IL-10 is elabor
ated from multiple sources and has diverse cellular effects to regulat
e immune and inflammatory responses. Accumulating evidence suggests th
at the anti-inflammatory influence of IL-10 Observed at the cellular l
evel may be manipulated to impact the immune and inflammatory-mediated
responses associated with injury and sepsis, gastrointestinal and car
diovascular disease, and transplantation. In conclusion, IL-10 is an i
mportant mediator of immune and anti-inflammatory responses in surgica
l disease and, as such, has therapeutic promise as an immunomodulator
and as an anti-inflammatory agent.